| --- | --- | |-------------------------------------------------------------------|-------| | | | | | | | | | | Bright Health Group Third Quarter 2023 – Earnings Presentation | | | November 7, 2023 | | Disclaimer Statements made in this presentation that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements and should be evaluated as such. Forward-looking statements include information concerning possible or assumed future results of o ...

Bright Health Group, Inc. (NYSE:BHG) Q3 2023 Earnings Conference Call November 7, 2023 8:00 AM ET Company Participants Stephen Hagan - Investor Relations Director Mike Mikan - Vice Chairman, CEO & President Jay Matushak - CFO Conference Call Participants Operator Hello, all, and welcome to Bright Health Group's third quarter 2023 earnings call. My name is Lydia, and I will be your operator today. It's my pleasure to now hand you over to your host, Stephen Hagan, Investor Relations Director to begin. Please ...

| --- | --- | |-------------------------------------------------------------------|-------| | | | | | | | | | | Bright Health Group Second Quarter 2023 – Earnings Presentation | | | August 9, 2023 | | Disclaimer Statements made in this presentation that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements and should be evaluated as such. Forward-looking statements include information concerning possible or assumed future results of op ...

Bright Health Group, Inc. (NYSE:BHG) Q2 2023 Earnings Conference Call August 9, 2023 8:30 AM ET Company Participants Stephen Hagan - IR, Director Mike Mikan - President and CEO Jay Matushak - CFO Conference Call Participants Operator Hello, and welcome to the Bright Health Group Q2 2023 Earnings Call. My name is Alex, and I will be coordinating the call today. I'll now hand over to your host, Stephen Hagan, Investor Relations Director to begin. Please go ahead. Stephen Hagan Good morning and welcome to Brig ...

NOTE 8. NET LOSS PER SHARE The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the three and six months ended June 30 (in thousands, except for per share amounts): | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-------------------|--------|-------- ...

Risk Adjustment: We record adjustments for changes to the risk adjustment balances for individual policies in premium revenue. The risk adjustment program adjusts premiums based on the demographic factors and health status of each consumer as derived from current-year medical diagnoses as reported throughout the year. Under the risk adjustment program, a risk score is assigned to each covered consumer to determine an average risk score at the individual and small-group level by legal entity in a particular ...

Not applicable. Table of Contents The following sets forth certain information regarding our executive officers as of March 6, 2023, including the business experience of each executive officer during the past five years: G. Mike Mikan has served as our Chief Executive Officer and President since April 2020. Mr. Mikan joined as our Vice Chairman and President in January 2019. Prior to joining Bright Health, Mr. Mikan served as Chairman and Chief Executive Officer of ShotRock Capital, LLC, a private investmen ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value BHG New York Stock Exchange UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fro ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value BHG New York Stock Exchange (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40537 Delaware 47-4991296 (State or other jurisdicti ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | |--------------------------------------------------------------------------------------------------------------|----------------------------------------------- ...